Effects of Exercise on VLDL-TG Metabolism

Effects of Exercise on VLDL-TG Metabolism in Individuals With NAFL and NASH

Non-alcoholic fatty liver disease (NAFLD) covers a spectrum from reversible hepatic steatosis to inflammation and fibrosis termed steatohepatitis (NASH) and cirrhosis. New evidence indicates that NAFLD is associated with development of heart failure, abnormal ventricular glucose and fatty acid (FA) utilisation and cardiosteatosis. The mechanisms behind cardiac involvement and the progression from NAFL to NASH are poorly understood but must include altered cardiac and intrahepatic lipid handling. In collaboration with renowned research groups from Oxford, Mayo Clinic and Copenhagen we plan comprehensive kinetic studies of heart and liver FA uptake and oxidation, ventricular function and substrate utilisation, and hepatic triglyceride (TG) secretion in order to assess mechanisms governing cardiac and hepatic lipid and glucose trafficking in subjects with NAFL and NASH and the relationship with heart function. In addition, we will assess skeletal muscle and adipose tissue enzyme activities, gene expression and protein concentrations in these subjects to define mechanisms involved in the cross-talk between heart, liver, muscle and adipose tissues. We will address these questions using innovative tracer techniques (11Cpalmitate, 11C acetate, 18FDG glucose PET tracers and TG tracers) in combination with hepatic vein catherisation to study cardiac and liver substrate trafficking, as well as NMR spectroscopy, echocardiography, muscle and fat biopsies in combination with state-of-the art muscle and adipose tissue enzyme kinetics, gene- and protein expression. Effects of acute exercise as well as GLP-1 agonist and SGLT-2 inhibitor treatment (alone and in combination) will be assessed. The overarching goals are to define abnormalities and differences between NAFLD and NASH in hepatic lipid (FA and TG) metabolism and to assess hepatic, adipose and skeletal muscle lipid and substrate utilisation.

Study Overview

• Status: Completed
• Conditions: NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease

• Study Type: Observational
• Enrollment (Actual): 19

Contacts and Locations

Study Locations

• Denmark
  • Aarhus N
    • Skejby, Aarhus N, Denmark, 8200
      • Arhus University Hospital Department of Endocrinology and Internal Medicine

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 40 years to 70 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Male

• Sampling Method: Probability Sample

Study Population

8 obese subject men with NAFL (MR spectroskopi, fibro scanner) (BMI > 30). 8 obese subject men with NASH (MR spectroskopi, fibro scanner) (BMI > 30).

• age between 40-70 years Written consent before the start of the study

Description

Inclusion Criteria:

• • 8 obese subject men with NAFL (MR spectroskopi, fibro scanner) (BMI > 30).

  • 8 obese subject men with NASH (MR spectroskopi, fibro scanner) (BMI > 30).
  • age between 40-70 years Written consent before the start of the study

Exclusion Criteria:

• known current disease
• Fixed medical drug consumption except antihypertensive drugs and statins. However, pause statins 3 weeks before the examination date
• Blood donation within the last 3 months prior to the study
• Participation in experiments involving radioactive isotopes within the last 3 months
• Alcohol abuse (over 21 items per week for men and 14 for women)
• Smoking
• Weight over 130 kg
• Cancer patients
• Large intake of medication

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Effects of exercise on VLDL-TG metabolism in individuals with NAFL or NASH	VLDL-TG turnover (µmol/min); To evaluate the acute effects of exercise on VLDL-TG secretion and clearance; To assess the uptake and cellular/intracellular regulation of FFA and VLDL-TG in fat and muscle tissue	3 years
Effects of exercise on VLDL-TG metabolism in individuals with NAFL or NASH	LPL-activity (µmol/time)	3 years

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Compare the acute effects of exercise in individuals with NAFL or NASH	Oxidation of VLDL-TG-FA(µmol/min)	3 years
Compare the acute effects of exercise in individuals with NAFL or NASH	FFA turnover (µmol/min)	3 years

Collaborators and Investigators

• Sponsor: University of Aarhus

Study record dates

Study Major Dates

• Study Start (Actual): December 1, 2018
• Primary Completion (Actual): November 10, 2020
• Study Completion (Actual): May 1, 2022

Study Registration Dates

• First Submitted: September 18, 2018
• First Submitted That Met QC Criteria: September 18, 2018
• First Posted (Actual): September 20, 2018

Study Record Updates

• Last Update Posted (Actual): May 24, 2022
• Last Update Submitted That Met QC Criteria: May 23, 2022
• Last Verified: May 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Digestive System Diseases; Liver Diseases; Fatty Liver; Non-alcoholic Fatty Liver Disease
• Other Study ID Numbers: Jeyanproject2

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No